SE0101773D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0101773D0
SE0101773D0 SE0101773A SE0101773A SE0101773D0 SE 0101773 D0 SE0101773 D0 SE 0101773D0 SE 0101773 A SE0101773 A SE 0101773A SE 0101773 A SE0101773 A SE 0101773A SE 0101773 D0 SE0101773 D0 SE 0101773D0
Authority
SE
Sweden
Prior art keywords
sub
ring
phenyl
novel compounds
compounds
Prior art date
Application number
SE0101773A
Other languages
English (en)
Inventor
William Brown
Andrew Griffin
Christopher Walpole
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101773A priority Critical patent/SE0101773D0/sv
Publication of SE0101773D0 publication Critical patent/SE0101773D0/sv
Priority to PL02367246A priority patent/PL367246A1/xx
Priority to US10/477,636 priority patent/US7008952B2/en
Priority to ARP020101818A priority patent/AR036231A1/es
Priority to BR0209665-0A priority patent/BR0209665A/pt
Priority to CA002446516A priority patent/CA2446516A1/en
Priority to JP2002591458A priority patent/JP2005508291A/ja
Priority to CNA028141687A priority patent/CN1527818A/zh
Priority to KR10-2003-7014951A priority patent/KR20040000472A/ko
Priority to EP02733713A priority patent/EP1395557A1/en
Priority to EEP200300526A priority patent/EE200300526A/xx
Priority to CZ20033093A priority patent/CZ20033093A3/cs
Priority to IL15870002A priority patent/IL158700A0/xx
Priority to SK1399-2003A priority patent/SK13992003A3/sk
Priority to HU0401610A priority patent/HUP0401610A2/hu
Priority to RU2003131963/04A priority patent/RU2003131963A/ru
Priority to PCT/SE2002/000957 priority patent/WO2002094785A1/en
Priority to MXPA03010444A priority patent/MXPA03010444A/es
Priority to ZA200308642A priority patent/ZA200308642B/en
Priority to BG108334A priority patent/BG108334A/bg
Priority to CO03100170A priority patent/CO5540320A2/es
Priority to IS7033A priority patent/IS7033A/is
Priority to NO20035119A priority patent/NO20035119D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
SE0101773A 2001-05-18 2001-05-18 Novel compounds SE0101773D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0101773A SE0101773D0 (sv) 2001-05-18 2001-05-18 Novel compounds
MXPA03010444A MXPA03010444A (es) 2001-05-18 2002-05-16 Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para tratamiento del dolor, ansiedad o trastornos gastrointestinales.
EEP200300526A EE200300526A (et) 2001-05-18 2002-05-16 4-(fenüül(piperidiin-4-üül)amino)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks
IL15870002A IL158700A0 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
ARP020101818A AR036231A1 (es) 2001-05-18 2002-05-16 Derivados de 4-diarilamino piperidina,procedimiento para su preparacion, empleo de estos derivados para la fabricacion de medicamentos, composicion farmaceutica y compuestos intermediarios
BR0209665-0A BR0209665A (pt) 2001-05-18 2002-05-16 Composto, processo para preparar o mesmo, uso de um composto, composição farmacêutica, e, métodos para o tratamento da dor, de distúrbios gastrintestinais funcionais, e da ansiedade
CA002446516A CA2446516A1 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
JP2002591458A JP2005508291A (ja) 2001-05-18 2002-05-16 ４−（フェニル−（ピペリジン−４−イル）−アミノ）−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用
CNA028141687A CN1527818A (zh) 2001-05-18 2002-05-16 4-(苯基-(哌啶-4-基)-氨基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用
KR10-2003-7014951A KR20040000472A (ko) 2001-05-18 2002-05-16 4-(페닐-(피페리딘-4-일)-아미노)-벤즈아미드 유도체 및통증,불안증 또는 위장관 장애의 치료를 위한 그의 용도
EP02733713A EP1395557A1 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
PL02367246A PL367246A1 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
CZ20033093A CZ20033093A3 (cs) 2001-05-18 2002-05-16 4-[Fenyl(piperidin-4-yl)amino]benzamidové deriváty a jejich použití pro ošetřování bolesti, úzkosti nebo gastrointestinálních poruch
US10/477,636 US7008952B2 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
SK1399-2003A SK13992003A3 (sk) 2001-05-18 2002-05-16 4-(Fenyl(piperidin-4-yl)amino)benzamidové deriváty a ich požitie na liečbu bolesti, anxiety alebo gastrointestinálnych porúch
HU0401610A HUP0401610A2 (hu) 2001-05-18 2002-05-16 4-[Fenil-(4-piperidinil)-amino]-benzamid-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
RU2003131963/04A RU2003131963A (ru) 2001-05-18 2002-05-16 Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
PCT/SE2002/000957 WO2002094785A1 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
ZA200308642A ZA200308642B (en) 2001-05-18 2003-11-05 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders.
BG108334A BG108334A (bg) 2001-05-18 2003-11-07 4-(фенил-(пиперидин-4-ил)-амино)-бензамидни производни и тяхното използване за лечение на болка, потиснатост или стомашно-чревни разстройства
CO03100170A CO5540320A2 (es) 2001-05-18 2003-11-12 Derivados de 4-(fenil-(piperidin-4-il)-amino)benzamida y sus usos para el tratamiento del dolor, la ansiedad o desordenes gastrointestinales
IS7033A IS7033A (is) 2001-05-18 2003-11-13 4-(fenýl-(píperidín-4-ýl)-amínó)-bensamíðafleiðurog notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
NO20035119A NO20035119D0 (no) 2001-05-18 2003-11-17 4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101773A SE0101773D0 (sv) 2001-05-18 2001-05-18 Novel compounds

Publications (1)

Publication Number Publication Date
SE0101773D0 true SE0101773D0 (sv) 2001-05-18

Family

ID=20284176

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101773A SE0101773D0 (sv) 2001-05-18 2001-05-18 Novel compounds

Country Status (23)

Country Link
US (1) US7008952B2 (sv)
EP (1) EP1395557A1 (sv)
JP (1) JP2005508291A (sv)
KR (1) KR20040000472A (sv)
CN (1) CN1527818A (sv)
AR (1) AR036231A1 (sv)
BG (1) BG108334A (sv)
BR (1) BR0209665A (sv)
CA (1) CA2446516A1 (sv)
CO (1) CO5540320A2 (sv)
CZ (1) CZ20033093A3 (sv)
EE (1) EE200300526A (sv)
HU (1) HUP0401610A2 (sv)
IL (1) IL158700A0 (sv)
IS (1) IS7033A (sv)
MX (1) MXPA03010444A (sv)
NO (1) NO20035119D0 (sv)
PL (1) PL367246A1 (sv)
RU (1) RU2003131963A (sv)
SE (1) SE0101773D0 (sv)
SK (1) SK13992003A3 (sv)
WO (1) WO2002094785A1 (sv)
ZA (1) ZA200308642B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140015122A (ko) 2003-10-01 2014-02-06 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN113979997A (zh) * 2021-11-12 2022-01-28 中国科学院昆明植物研究所 N,n-(4-哌啶基、芳基)-3-氨基苯酚类衍生物及其药物组合物和其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091096A (en) 1976-03-19 1978-05-23 Eli Lilly And Company Dinitroanilines for the control of phytopathogens
EG12406A (en) 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE441448B (sv) 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar
US4252812A (en) 1977-05-23 1981-02-24 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
DE3200304A1 (de) 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
EP0181793B1 (fr) 1984-10-16 1988-07-27 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique
KR940003491B1 (ko) 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
YU150489A (sh) 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
US5854245A (en) 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
AU2009799A (en) 1997-12-24 1999-07-19 Ortho-Mcneil Pharmaceutical, Inc. 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor
AU756983B2 (en) 1998-03-10 2003-01-30 Research Triangle Institute Novel opiate compounds, methods of making and methods of use
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
IL151550A0 (en) * 2000-03-03 2003-04-10 Ortho Mcneil Pharm Inc 3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
SE0001207D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds

Also Published As

Publication number Publication date
EP1395557A1 (en) 2004-03-10
IS7033A (is) 2003-11-13
HUP0401610A2 (hu) 2004-12-28
RU2003131963A (ru) 2005-05-10
US7008952B2 (en) 2006-03-07
IL158700A0 (en) 2004-05-12
WO2002094785A1 (en) 2002-11-28
US20040142966A1 (en) 2004-07-22
BR0209665A (pt) 2004-04-20
NO20035119D0 (no) 2003-11-17
JP2005508291A (ja) 2005-03-31
PL367246A1 (en) 2005-02-21
AR036231A1 (es) 2004-08-25
BG108334A (bg) 2004-12-30
CZ20033093A3 (cs) 2004-07-14
MXPA03010444A (es) 2004-03-09
KR20040000472A (ko) 2004-01-03
ZA200308642B (en) 2005-02-07
EE200300526A (et) 2004-02-16
CN1527818A (zh) 2004-09-08
CA2446516A1 (en) 2002-11-28
SK13992003A3 (sk) 2004-04-06
CO5540320A2 (es) 2005-07-29

Similar Documents

Publication Publication Date Title
WO2002094794A8 (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0001207D0 (sv) Novel compounds
SE0101765D0 (sv) Novel compounds
SE0103313D0 (sv) Novel compounds
SE0101766D0 (sv) Novel compounds
SE0001209D0 (sv) Novel compounds
SE0001208D0 (sv) Novel compounds
SE0101768D0 (sv) Novel compounds
SE9904673D0 (sv) Novel compounds
BG106805A (en) Novel compounds
BG106807A (en) Novel compounds
SE0101767D0 (sv) Novel compounds
SE0101771D0 (sv) Novel compounds
SE0101769D0 (sv) Novel compounds
SE0101773D0 (sv) Novel compounds
SE0101770D0 (sv) Novel compounds
SE0101772D0 (sv) Novel compounds